Browse our anti-SRA1 (SRA1) Antibodies

Full name:
anti-Steroid Receptor RNA Activator 1 Antibodies (SRA1)
On www.antibodies-online.com are 67 Steroid Receptor RNA Activator 1 (SRA1) Antibodies from 16 different suppliers available. Additionally we are shipping SRA1 Proteins (7) and many more products for this protein. A total of 80 SRA1 products are currently listed.
Synonyms:
AA959952, CD204, CMD1, CMPD1, E030028J09Rik, l(7)1Rl, l7Rl1, l71Rl, mKIAA0068, P140SRA-1, P140sra1, phSR1, phSR2, pl-1, pp7684, SCARA1, Shyc, SR-A, Sra, Sra-1, SRA1, Srap, Straa1, Strra1

Most Popular Reactivities for anti-SRA1 (SRA1) Antibodies

Select your species and application

anti-Mouse (Murine) SRA1 Antibodies:

anti-Human SRA1 Antibodies:

anti-Rat (Rattus) SRA1 Antibodies:

All available anti-SRA1 Antibodies

Go to our pre-filtered search.

Top referenced anti-SRA1 Antibodies

  1. Human Monoclonal SRA1 Primary Antibody for IHC (p), WB - ABIN1109138 : Lanz, Chua, Barron, Söder, DeMayo, OMalley: Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. in Molecular and cellular biology 2003 (PubMed)
    Show all 3 references for 1109138

  2. Human Monoclonal SRA1 Primary Antibody for ELISA, IHC - ABIN2869196 : Chooniedass-Kothari, Hamedani, Troup, Hubé, Leygue: The steroid receptor RNA activator protein is expressed in breast tumor tissues. in International journal of cancer. Journal international du cancer 2006 (PubMed)
    Show all 3 references for 2869196

  3. Human Polyclonal SRA1 Primary Antibody for IHC (p), IP - ABIN250657 : Khaleel, Dorheim, Duryee, Durbin, Bussey, Garvin, Klassen, Thiele, Anderson: High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure. in The Annals of thoracic surgery 2012 (PubMed)
    Show all 2 references for 250657

  4. Human Monoclonal SRA1 Primary Antibody for IP, ELISA - ABIN1742561 : Bozdagi, Sakurai, Dorr, Pilorge, Takahashi, Buxbaum: Haploinsufficiency of Cyfip1 produces fragile X-like phenotypes in mice. in PLoS ONE 2012 (PubMed)
    Show all 2 references for 1742561

More Antibodies against SRA1 Interaction Partners

Mouse (Murine) Steroid Receptor RNA Activator 1 (SRA1) interaction partners

  1. Visfatin (show NAMPT Antibodies) upregulated CD36 (show CD36 Antibodies) and SRA (show MSR1 Antibodies) expression and downregulated ABCA1 (show ABCA1 Antibodies) and ABCG1 (show ABCG1 Antibodies) expression, subsequently increased ox-LDL uptake and decreased cholesterol efflux, and finally promoted foam cell formation via the PI3K- and ERK (show EPHB2 Antibodies)-dependent pathways.

  2. In Cyfip1 (show CYFIP1 Antibodies)-deficient mice, parental origin determines the impairment of synaptic functions and behavior.

  3. Data suggest that MAP kinase (show MAPK1 Antibodies)-interacting kinases (Mnk1 (show MKNK1 Antibodies), Mnk2 (show MKNK2 Antibodies)) regulate cell migration/wound healing, expression of vimentin (show VIM Antibodies), stability of vimentin (show VIM Antibodies) protein, and binding of cytoplasmic eIF4E (eukaryotic translation initiation factor 4E (show EIF4E Antibodies)) and Cyfip1 (show CYFIP1 Antibodies).

  4. The results of this study demonstrated that SRA (show MSR1 Antibodies) could attenuate microglia mediated inflammation injury in ICH (show ACE Antibodies). In addition, SRA (show MSR1 Antibodies) mediated negative feedback mechanism in neuroimmune homeostasis.

  5. these data are the first to indicate a functional role for SRA (show MSR1 Antibodies) in adipose tissue biology and glucose homeostasis in vivo.

  6. CYFIP2 (show CYFIP2 Antibodies) is a key regulator of cocaine response in mammals and present a framework to use mouse substrains to identify previously unknown genes and alleles regulating behavior.

  7. This study demonistrated that CYFIP1 (show CYFIP1 Antibodies) coordinates mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine formation.

  8. haploinsufficiency of Cyfip1 (show CYFIP1 Antibodies) mimics key aspects of the phenotype of Fmr1 (show FMR1 Antibodies) knockout mice and are consistent with the hypothesis that these effects are mediated by interaction of Cyfip1 (show CYFIP1 Antibodies) and Fmrp (show FMR1 Antibodies) in regulating activity-dependent translation.

  9. Dax1 (show NR0B1 Antibodies) augmentation of LRH-1 (show NR5A2 Antibodies)-mediated Oct4 (show POU5F1 Antibodies) activation is dependent upon steroid receptor (show ESR2 Antibodies) RNA activator

  10. DEAD-box RNA helicase (show DDX56 Antibodies) p68 (DDX5 (show DDX5 Antibodies)) and its associated noncoding RNA, steroid receptor (show ESR2 Antibodies) RNA activator (SRA (show MSR1 Antibodies)), form a complex with CTCF (show CTCF Antibodies) that is essential for insulator function

Human Steroid Receptor RNA Activator 1 (SRA1) interaction partners

  1. These findings suggest that SOX9 (show SOX9 Antibodies) may play an important role in tumor progression of Renal Cell Carcinoma (show MOK Antibodies) and Bladder Cancer and it may be used as a biomarker of this malignancy.

  2. Loss of DDRGK1 decreases SOX9 (show SOX9 Antibodies) expression and causes a human skeletal dysplasia.

  3. The expression of EVI1 (show MECOM Antibodies) and SOX9 (show SOX9 Antibodies) is associated with stem cell-like and metastasis signatures, and their depletion impairs the metastatic potential of breast cancer cells. These results establish the mechanistic link between resistance to mTOR (show FRAP1 Antibodies) inhibition and cancer metastatic potential, thus enhancing our understanding of mTOR (show FRAP1 Antibodies) targeting failure

  4. regulation of cancer stem cell via SLUG (show SNAI2 Antibodies)-SOX9 (show SOX9 Antibodies) regulatory axis

  5. data indicate that SOX9 (show SOX9 Antibodies) expression drives prostate cancer by reactivating the WNT (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling that mediates ductal morphogenesis in fetal prostate and define a subgroup of patients who would benefit from WNT (show WNT2 Antibodies)-targeted therapy.

  6. Low levels of SOX9 (show SOX9 Antibodies) in primary stage II colon tumors predicts high risk of relapse.

  7. ELF3 (show ELF3 Antibodies) interacts directly with the HMG (show SSRP1 Antibodies) domain of Sox9 (show SOX9 Antibodies). Importantly, overexpression of ELF3 (show ELF3 Antibodies) significantly decreased Sox9 (show SOX9 Antibodies)/CBP (show CREBBP Antibodies)-dependent HAT (show MGEA5 Antibodies) activity.

  8. SR-A1 suppresses lung cancer metastasis by downregulating SAA1 (show SAA1 Antibodies) production in tumor-associated macrophages (TAM (show CCNA1 Antibodies)).

  9. PTX2 (show APCS Antibodies) was identified PTX2 (show APCS Antibodies) as a novel partner for FX, and both proteins cooperated to prevent their SR-AI (show MSR1 Antibodies)-mediated uptake by macrophages.

  10. SOX9 (show SOX9 Antibodies) is required for chondrogenesis: it secures chondrocyte lineage commitment, promotes cell survival, and transcriptionally activates the genes for many cartilage-specific structural components and regulatory factors.

SRA1 Antigen Profile

Antigen Summary

Both long non-coding and protein-coding RNAs are transcribed from this gene, and they represent alternatively spliced transcript variants. This gene was initially defined as a non-coding RNA, which is a coactivator for several nuclear receptors (NRs) and is associated with breast cancer. It has now been found that this gene is involved in the regulation of many NR and non-NR activities, including metabolism, adipogenesis and chromatin organization. The long non-coding RNA transcripts interact with a variety of proteins, including the protein encoded by this gene. The encoded protein acts as a transcriptional repressor by binding to the non-coding RNA.

Alternative names and synonyms associated with SRA1

  • cytoplasmic FMR1 interacting protein 1 (Cyfip1) antibody
  • macrophage scavenger receptor 1 (MSR1) antibody
  • SRY (sex determining region Y)-box 9 (SOX9) antibody
  • steroid receptor RNA activator 1 (SRA1) antibody
  • steroid receptor RNA activator 1 (Sra1) antibody
  • AA959952 antibody
  • CD204 antibody
  • CMD1 antibody
  • CMPD1 antibody
  • E030028J09Rik antibody
  • l(7)1Rl antibody
  • l7Rl1 antibody
  • l71Rl antibody
  • mKIAA0068 antibody
  • P140SRA-1 antibody
  • P140sra1 antibody
  • phSR1 antibody
  • phSR2 antibody
  • pl-1 antibody
  • pp7684 antibody
  • SCARA1 antibody
  • Shyc antibody
  • SR-A antibody
  • Sra antibody
  • Sra-1 antibody
  • SRA1 antibody
  • Srap antibody
  • Straa1 antibody
  • Strra1 antibody

Protein level used designations for SRA1

cytoplasmic FMR1-interacting protein 1 , specifically Rac1-associated protein 1 , macrophage acetylated LDL receptor I and II , macrophage scavenger receptor type III , macrophage scavenger receptor types I and II , scavenger receptor class A member 1 , scavenger receptor class A, member 1 , SRY (sex-determining region Y)-box 9 protein , SRY-related HMG-box, gene 9 , transcription factor SOX-9 , steroid receptor RNA activator 1 (complexes with NCOA1) , steroid receptor RNA activator protein , steroid receptor coactivator , SRAP

GENE ID SPECIES
20430 Mus musculus
4481 Homo sapiens
6662 Homo sapiens
10011 Homo sapiens
24068 Mus musculus
252891 Rattus norvegicus
Selected quality suppliers for anti-SRA1 (SRA1) Antibodies
Did you look for something else?